117 related articles for article (PubMed ID: 20611005)
21. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
[TBL] [Abstract][Full Text] [Related]
23. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
24. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ
J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
Gatselis NK; Georgiadou SP; Koukoulis GK; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
[TBL] [Abstract][Full Text] [Related]
26. Serological markers of autoimmunity in patients infected with hepatitis C virus: impact of HIV co-infection.
Adeyemi OM; Attar B; Jensen D; Ghaoui R; Cotler SJ
HIV Med; 2005 Nov; 6(6):371-4. PubMed ID: 16268816
[TBL] [Abstract][Full Text] [Related]
27. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
28. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
Szanto P; Grigorescu M; Dumitru I; Serban A
J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
[TBL] [Abstract][Full Text] [Related]
29. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
[TBL] [Abstract][Full Text] [Related]
30. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C.
Chen CH; Lee CM; Chen CH; Hu TH; Wang JH; Hung CH; Chung CH; Lu SN
Chang Gung Med J; 2010; 33(3):258-65. PubMed ID: 20584503
[TBL] [Abstract][Full Text] [Related]
32. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
33. Lupus membranous glomerulonephritis mimicking hepatitis C-associated nephropathy.
Danesh FR; Lynch P; Kanwar YS
Am J Kidney Dis; 2002 Mar; 39(3):E19. PubMed ID: 11877599
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection.
Peng YC; Hsieh SC; Yang DY; Tung CF; Hu WH; Huang WN; Chen GH
J Clin Gastroenterol; 2001; 33(5):402-6. PubMed ID: 11606858
[TBL] [Abstract][Full Text] [Related]
35. Should patients with chronic hepatitis C who have normal ALT levels be treated?
Russo MW; Brown RS
Curr Gastroenterol Rep; 2001 Feb; 3(1):49-53. PubMed ID: 11177694
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlates of the "rods and rings" antinuclear antibody pattern.
Climent J; Morandeira F; Castellote J; Xiol J; Niubó J; Calatayud L; Mestre M; Bas J
Autoimmunity; 2016; 49(2):102-8. PubMed ID: 26699543
[TBL] [Abstract][Full Text] [Related]
37. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study.
Gatselis NK; Georgiadou SP; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
World J Gastroenterol; 2005 Jan; 11(4):482-7. PubMed ID: 15641130
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype.
Luo JC; Hwang SJ; Li CP; Lu RH; Chan CY; Wu JC; Chang FY; Lee SD
J Gastroenterol Hepatol; 1998 May; 13(5):475-9. PubMed ID: 9641643
[TBL] [Abstract][Full Text] [Related]
39. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.
Stroffolini T; Colloredo G; Gaeta GB; Sonzogni A; Angeletti S; Marignani M; Pasquale G; Venezia G; Craxì A; Almasio P
J Viral Hepat; 2004 May; 11(3):257-62. PubMed ID: 15117328
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody profile in individuals with chronic hepatitis C.
Marconcini ML; Fayad L; Shiozawa MB; Dantas-Correa EB; Lucca Schiavon Ld; Narciso-Schiavon JL
Rev Soc Bras Med Trop; 2013; 46(2):147-53. PubMed ID: 23740063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
